Clinical outcomes in patients with hepatitis D, cirrhosis and persistent hepatitis B virus replication, and receiving long-term tenofovir or entecavir.

Giuseppina BrancaccioMassimo FasanoAdriano GrossiTeresa Antonia SantantonioGiovanni Battista Gaeta

Published in: Alimentary pharmacology & therapeutics (2019)

Patients with HDV infection and advanced liver disease maintain an increased risk of severe clinical events as compared with HBV monoinfected patients, during prolonged HBV DNA suppression with potent NA.

Keyphrases

hepatitis b virus
liver failure
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
early onset
circulating tumor
cell free
anti inflammatory
patient reported